Skip to content
Home › 13F recaps › Q3 2026 › TEVAN

Which funds bought or sold TEVAN in Q3 2026?

Teva Pharmaceutical Inds Ltd. 0 funds bought, 7 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$552M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold TEVAN, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (0)

None of the tracked funds.

Sold (7)

FundChangeEst. $Now
BlackRock
Index giant
Sold out−$2.2B—
Geode
Index giant
Sold out−$391M—
Wellington
Asset manager
Sold out−$260M—
Glenview
Hedge fund
Sold out−$172M—
DME / Greenlight
Value investor
Sold out−$98M—
Duquesne
Family office & foundation
Sold out−$21M—
Farallon
Hedge fund
Sold out−$1M—

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.